Insulin treatment in children with newly diagnosed T1DM is associated with improvements in muscle mass and strength during early follow-up. Regular glycemic control and insulin therapy may contribute to delaying or mitigating complications related to impaired muscle development. Longitudinal studies are warranted to explore the long-term musculoskeletal outcomes of insulin therapy in pediatric T1DM.
Özdemir et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: